Review Article

Neural Plasticity in Common Forms of Chronic Headaches

Table 1

Neural plasticity in episodic and chronic migraine, without medication overuse.

Episodic migraine (EM)Chronic migraine (CM)

Electrophysiology
 VEPLack of habituation and peri-ictal normalization [14]No specific study
 MEGPeri-ictal normalization of visual cortical excitability, reflecting a dynamic modulation of cortical activities [15]Persistent ictal-like visual cortex excitability [16]; in patients who remitted from CM to EM, the MEG pattern shifted to that characterizing EM between attacks, that is, decreased initial amplitude with subsequent deficient habituation [17]
 TMSHyperexcitability measured by TMS indices of phosphene thresholds and magnetic suppression of perceptual accuracy [18]Reduced visual suppression correlating with high cortical excitability [18, 19]
 SSEPAbnormal habituation during interictal period and central sensitization (increase of N20-P25 amplitude) during ictal period [14]Increase of N20-P25 amplitudes recorded interictally in patients with CM compared with in patients with EM, indicating excessive cortical activation of the somatosensory pathway [20]
 BAEPLack of habituation of wave IV-V, especially with symptomatic vertigo [14]No specific study
 LEPLack of habituation of N1 (generated by secondary somatosensory cortex) and N2-P2 (generated by ACC and insula) during interictal and ictal periods
Sensitization represented by increased N2-P2 amplitude in the ipsilateral headache side during ictal period [14]
Increase of amplitudes and rostral shift within ACC in patients with CM, similar to EM patients in the ictal period [21, 22]

Neuroimaging
 Functional
  PETActivation of certain brain areas during ictal period indicating the involvement of specific brain areas associated with various symptoms in migraine including photophobia, nausea, and vertigo [2326]
Ligand PET: changes of serotonin and opioid receptors and activities, indicating possible roles these neurotransmitters play and related neural plasticity associated with migraine [27, 28]
Increased cerebral metabolism at brainstem compared to the global flow and also decreased cerebral metabolism in the medial frontal, parietal, and somatosensory cortex, indicating a potential dysfunction in the inhibitory pathways [19]
  fMRIGreater activation of pain-matrix areas and less activation of pain inhibition areas [29]No specific study
  rs-fMRIAberrant functional connectivity mostly in pain-matrix and also involving different networks including salience, default mode, central-executive, somatomotor, and frontoparietal attention networks [29]Aberrant functional connectivity in affective pain regions including anterior insula, amygdala, pulvinar, mediodorsal thalamus, middle temporal cortex, and periaqueductal gray [30]
 Structural
  VBMDecrease of gay matter volume of multiple brain areas within pain-matrix [3137] No specific study; only two studies recruited small numbers of CM patients (11 and 3 patients each) without definite conclusions [33, 35]
  SBMIncrease thickness of the somatosensory cortex and visual motion areas [38, 39]; no changes [40]; thickness of somatosensory cortex decrease in low frequency (1-2 days/month) and increase in high frequency (8–14 days/month) [41]; mixed results of increase and decrease of cortical thickness in other brain areas [42, 43] No specific study
  DTIChanges of white matter microstructures in areas such as corpus callosum and cingulate gyrus [36, 4450]
Dynamic alteration of fractional anisotropy noted at thalami, in relation with peri-ictal/ictal status [51]
No changes in one study recruiting both CM and EM patients [52]
 Biochemical
  MRSHigher NAA/Cr ratio at dorsal pons, indicating possible neuronal hypertrophy; inverse correlation with headache frequency and intensity [53]
Changes of the excitatory glutamate in the ACC and insula, indicating [54]
Lower NAA/Cr as compared with EM with inverse correlation with headache frequency and intensity, indicating possible progression of neuronal loss during evolution [53]

VEP: visual evoked potential, MEG: magnetoencephalography, TMS: transcranial magnetic stimulation, SSEP: somatosensory evoked potential, BAEP: brainstem auditory evoked potential, LEP: laser evoked potential, ACC: anterior cingulate cortex, PET: positron emission topography, fMRI: functional magnetic resonance imaging, rs-fMRI: resting state functional magnetic resonance imaging; VBM: voxel-based morphometry, SBM: surface-based morphometry, DTI: diffusion tensor imaging, MRS: magnetic resonance spectroscopy, and NAA/Cr: N-acetylaspartate/creatine.